Clinical Resources

ACOG Practice Bulletin #121 (Reaffirmed 2015): Long-Acting Reversible Contraception - Implants and Intrauterine Devices

This Practice Bulletin provides recommendations for the use of IUDs and contraceptive implants, the most effective reversible contraceptives. The document provides information for appropriate candidate selection and the management of clinical issues and complications associated with LARC methods. The LARC Program has also developed an educational slide set based on clinical recommendations from this Practice Bulletin.

ACOG Committee Opinion #672 (2016): Clinical Challenges of Long-Acting Reversible Contraceptive Methods

This Committee Opinion provides recommendations to aid in the diagnosis and treatment of the most common challenges encountered with LARC, such as difficult IUD insertion, nonpalpable implants, nonvisualized strings, and pelvic inflammatory disease (PID). 

ACOG Committee Opinion #670 (2016): Immediate Postpartum Long-Acting Reversible Contraception

This Committee Opinion encourages prenatal counseling of the most effective options for postpartum contraception: IUDs and the implant. Providers should counsel women about the convenience and effectiveness of immediate postpartum LARC, as well as the benefits of reducing unintended pregnancy and lengthening interpregnancy intervals. 

ACOG Committee Opinion #642 (2015): Increasing Access to Contraceptive Implants and Intrauterine Devices To Reduce Unintended Pregnancy

This Committee Opinion encourages the consideration of implants and IUDs for all appropriate candidates, including nulliparous women and adolescents, and recommends strategies to reduce barriers and increase access to LARC as part of the entire family of contraceptive methods.

ACOG Committee Opinion #542 (2012): Access to Emergency Contraception 

This Committee Opinion examines the barriers to use of emergency contraceptive methods and highlights the importance of increasing access to these methods. Age restrictions, cost, insurance coverage, and misconceptions about EC are all unnecessary barriers that continue to keep women from using this safe and effective method to prevent unwanted pregnancies in the first few days after unprotected sex, sexual assault, or contraceptive failure.

ACOG Committee Opinion #539 (Reaffirmed 2014): Adolescents and Long-Acting Reversible Contraception - Implants and Intrauterine Devices

This Committee Opinion recommends the use of IUDs and the contraceptive implant as first-line contraceptive options for sexually active adolescents. The LARC Program has also developed an educational slide set based on clinical recommendations from this Committee Opinion.


Other Resources

CDC: US Selected Practice Recommendations for Contraceptive Use, 2016

The CDC released this resource offering guidance to health care providers in managing common issues around the initiation and use of specific contraceptive methods. The US Selected Practice Recommendations (US SPR) was produced as a companion piece to the US Medical Eligibility Criteria for Contraceptive Use, 2016. While the US Medical Eligibility Criteria addresses who can use various contraceptive methods, the US Selected Practice Recommendations offers method-specific guidance on common clinical issues, such as what clinical information is needed before method initiation and how to manage side effects. 

CDC: Contraception App for Android and iOS Based on the 2016 US MEC and US SPR

The CDC has developed apps for Android (Google Play Store) and iOS (Apple App Store) based on the US Medical Eligibility Criteria for Contraceptive Use, 2016 (2016 US MEC) and the US Selected Practice Recommendations for Contraceptive Use, 2016 (2016 US SPR), which give providers an interactive way to access more than 1,800 recommendations for the safety of contraceptive methods among women and men with certain characteristics or medical conditions.  You can also download or order updated guidance documents, provider tools, and other electronic resources as they become available on the CDC Contraceptive Guidance for Health Care Providers website.

Journal of Adolescent Health: April 2013 Supplement on Long Acting Reversible Contraceptives for Adolescents and Young Adults

This supplement features a broad range of current research on LARC, covering topics such as effective contraceptive counseling strategiesmyths about LARCpelvic inflammatory disease and IUD usecost as a barrier to LARC use in adolescents, and the effect of LARC on rapid repeat pregnancy in adolescents.


The resources listed above are for information purposes only. Referral to these sources and sites does not imply the endorsement of ACOG. Further, ACOG does not endorse any commercial products that may be advertised or available from these organizations or on these web sites. These lists are not meant to be comprehensive. The exclusion of a source or site does not reflect the quality of that source or site. Please note that sites and URLs are subject to change without notice.

The information contained in slide sets is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. This information should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.

Contact:

Mica Bumpus
Manager, LARC Program
mbumpus@acog.org

For media inquiries about LARC, please contact:
communications@acog.org
202.863.3321

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998